Virology and Bacteriology Market to Grow at 12% through 2025
Constantly rising incidence of infectious diseases to drive
global virology and bacteriology market
According
to TechSci Research report, “Global
Virology
and Bacteriology Market By Technology, By Disease,
By End User, By Region, Competition, Forecast & Opportunities, 2025”, the
global virology and bacteriology market is project to witness a CAGR of 12% during 2021- 2025, majorly on account of continuously
growing cases of infectious diseases worldwide coupled with advances in
molecular diagnostic technologies. Also, continuing spread of AIDS and rising threat
of bioterrorism is making headway for the growth of global virology and
bacteriology market across the globe. Along with this, supportive government
funding, reimbursement policies and increasing investments by public and
private bodies is expected to fuel the market growth during the next five
years. However, there are some factors that can act as major impediments to the
growth of global virology and bacteriology market through 2025 such as concerns
pertaining to reimbursement policies and regulatory scenarios in various
countries.
Browse 152
market data Figures spread through 120 Pages
and an in-depth TOC on " Global Virology and
Bacteriology Market "
https://www.techsciresearch.com/report/virology-and-bacteriology-market/4700.html
Global
virology and bacteriology market can be segmented based on technology, disease,
end user, and region. Considering the end user segmentation, the market is
fragmented into clinics, hospitals, diagnostic centers, research laboratories, and blood banks. The research laboratories segment dominated the global
virology and bacteriology market until 2019 and is further anticipated to
maintain its dominance during the forecast period as well. In term of disease, the market is segregated
into respiratory system, urinary tract, and bloodstream diseases;
gastrointestinal and periodontal diseases; sexually transmitted diseases. Respiratory
system segment accounted for largest market share in 2019 and is further
anticipated to grow at a high pace over the next five years on account of increase
in population suffering from respiratory disorders.
Download
sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4700
customers can also request for 10% free
customization on this report.
Fujirebio Diagnostics
Inc., Cepheid Inc., DiaSorin S.p.A., Bio-Rad Laboratories Inc., Thermo Fisher
Scientific Inc., Scienion AG, Grifols S.A., Qiagen N.V., Eiken Chemical Co Ltd,
Sequenom Inc., bioMerieux SA, Siemens AG, Hologic Inc., Diamedix Corporation,
Leica Biosystems Nussloch GmbH, F. Hoffmann-La Roche AG, Abbott Laboratories,
GSK Biologicals SA are
among the leading players operating in the global virology and bacteriology
market. “North America is forecast to dominate the global virology and
bacteriology market though 2025 on account of rapid adoption of advanced
diagnostic and testing methods in the region. Furthermore, rising spending on
healthcare, presence of advanced clinical laboratories and medical device
manufacturing companies and favorable government policies, is also contributing
to the growing trend. However, Asia-Pacific is forecast to register highest
CAGR over the forecast period, which can be attributed to expanding research
and development facilities in the field of diagnostics across the region.”,
said Mr. Karan Chechi, Research Director with TechSci Research, a research based
global management consulting firm.
“Global Virology and Bacteriology Market By Technology,
By Disease, By End User, By Region, Competition, Forecast & Opportunities,
2025” has
evaluated the future growth potential of global virology and bacteriology market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in global virology and bacteriology market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]